Common Sensing said today that it has enlisted design company Flex to help redesign its Gocap insulin pen device. Flex is tasked with finding materials to help extend the product’s battery life, as well as boost measurement accuracy and prepare for high volume manufacturing. Get the full story at our sister site, Drug Delivery Business News.
Flex has recently expanded its digital health capabilities through a partnership with Google Cloud Platform — launching its BrightInsight managed service that delivers real-time information about connected drug, device or combination products. BrightInsight is a secure, managed services solutions that runs on Google Cloud Platform to gather data. “We saw the need for a secure […]
Flex today posted second quarter 2018 earnings results that met expectations on Wall Street. The San Jose, Calif.-based company posted profits of $205.1 million, or 38¢ per share, on sales of $6.3 billion for the 3 months ended September 30, seeing the bottom line swing from $2.5 million in the red while sales grew 4.4% […]
The wearable lab at Flex (formerly Flextronics) reports it’s making strides when it comes to creating devices that are transparent and seamless. “Usually when you think about healthcare, you picture a person in a bed with wires running all around. We think healthcare should be as easy as putting on a T-shirt,” said John Carlson, president of health […]